Form 4: 89bio Executive Receives 95,000 Restricted Stock Units

An 89bio executive, Quoc Le-Nguyen, was granted 95,000 restricted stock units on December 12, 2024.

Summary

• Quoc Le-Nguyen, Chief Technical Operations Officer at 89bio, Inc., received 95,000 restricted stock units on December 12, 2024.
• These restricted stock units vest in equal semi-annual installments over two years, contingent upon continued service to the company.
• Following this transaction, Mr. Le-Nguyen directly owns 282,796 shares of 89bio common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally positive for aligning interests, but not a major market-moving event.

Positives

• The grant of restricted stock units aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and commitment from the executive.

Risks

• The value of the restricted stock units is subject to market fluctuations and the company's performance.
• The executive's departure before full vesting would result in forfeiture of unvested units.

Future Outlook

The restricted stock units will vest over the next two years, subject to the executive's continued service.

Industry Context

Stock-based compensation is a common practice in the biotechnology industry to attract and retain key talent.

Comparison to Industry Standards

• Stock grants are a standard form of compensation for executives in the biotech industry, often used to align their interests with shareholders.
• Vesting schedules, such as the semi-annual vesting over two years, are typical for restricted stock units in similar companies.
• Comparable companies in the biotech space, such as Madrigal Pharmaceuticals and Viking Therapeutics, also utilize stock-based compensation as part of their executive pay packages.

Stakeholder Impact

• The stock grant may have a minor dilutive effect on existing shareholders.
• The vesting schedule incentivizes the executive to contribute to the company's long-term success, which is beneficial for all stakeholders.

Key Dates

Keywords

restricted stock units, stock grant, executive compensation, insider trading, 89bio, ETNB, Quoc Le-Nguyen